Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer.

Frontiers in immunology - 1 Jan 2021

Ye Fangdie, Hu Yun, Gao Jiahao, Liang Yingchun, Liu Yufei, Ou Yuxi, Cheng Zhang, Jiang Haowen

Abstract excerpt

We aimed to develop a noninvasive radiomics approach to reveal the m6A methylation status and predict survival outcomes and therapeutic responses in patients. A total of 25 m6A regulators were selected for further analysis, we confirmed that expression level and genomic mutations rate of m6A regulators were significantly different between cancer and normal tissues. Besides, we constructed methylation modification...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine
Share to Computational Biology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Databases, Genetic

Share to Kaplan-Meier Estimate

Share to Methylation

Share to ROC Curve

Share to Tomography, X-Ray Computed

Share to Urinary Bladder Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34733275
DOI: 10.3389/fimmu.2021.722642
PMCID: PMC8559436

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Radiogenomics Map Reveals the Landscape of m6A Methylation Modification Pattern in Bladder Cancer.PMID 34733275Read ↗

Development of an m6A subtype classifier to guide precision therapy for patients with bladder cancerSemantic proximity Read ↗

M5C modulator mediated methylation pattern and TME cell infiltration in bladder cancerSemantic proximity Read ↗

Identification and Validation of N6-methyladenosine-related Biomarkers for Bladder Cancer: Implications for ImmunotherapySemantic proximity Read ↗

m6A-Mediated Tumor Invasion and Methylation Modification in Breast Cancer MicroenvironmentSemantic proximity Read ↗

An m1A/m6A/m7G/m5C regulator-mediated methylation modification pattern and Landscape of immune microenvironment infiltration characterization in Lower-Grade Glioma cohorts from three continents based on machine learningSemantic proximity Read ↗

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder CancerSemantic proximity Read ↗

Identification of a novel RNA modifications-related model to improve bladder cancer outcomes in the framework of predictive, preventive, and personalized medicineSemantic proximity Read ↗

Subtypes of m6A RNA Modification Defines Tumor Microenvironment, Immunotherapy and Pharmacogenomic Landscape in Prostate CancerSemantic proximity Read ↗

N6-Methylandenosine-Related lncRNAs Predict Prognosis and Immunotherapy Response in Bladder CancerSemantic proximity Read ↗

Comprehensive Characterization of m6A Regulators-Mediated Methylation Modification Patterns and Tumor Microenvironment Signature in Breast CancerSemantic proximity Read ↗

m6A regulator-mediated methylation modification patterns and characteristics of immunity and stemness in low-grade glioma.Semantic proximity Read ↗

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.